How were Diadexus' earnings last quarter?

Diadexus, Inc. (OTCMKTS:DDXS) announced its quarterly earnings results on Monday, October, 26th. The company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.69) by $0.35.

What other stocks do shareholders of Diadexus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diadexus investors own include GoPro (GPRO) , General Electric (GE) , Ambarella (AMBA) and Alliqua Biomedical (ALQA) .

How do I buy shares of Diadexus?

Shares of DDXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:DDXS

Diadexus (DDXS) Stock Price, News & Analysis

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

Free DDXS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 30 shs
Average Volume: 15,481 shs
Market Capitalization: $53,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Diadexus alerts:

Ad Paradigm Press

Never use this word on your phone (FBI could be watching)

This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...

Watch my unredacted video about what I think is coming next right here

About Diadexus Stock (OTCMKTS:DDXS)

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

Ad Paradigm Press

Never use this word on your phone (FBI could be watching)

This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...

Watch my unredacted video about what I think is coming next right here

DDXS Stock News Headlines

September 20, 2023 | investing.com

DDXSQ Historical Data

June 21, 2023 | investing.com

Truen Co Ltd (417790)

May 5, 2024 | Stansberry Research (Ad)

Gold Mania

Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).

April 9, 2023 | marketwatch.com

The Global Molecular Diagnostic Product Market from 2023-2028 | Exploring Untapped Potential

October 26, 2021 | finance.yahoo.com

Diadexus, Inc. to File Chapter 7

See More Headlines

Receive DDXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diadexus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/26/2015
Today: 5/05/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:DDXS
CUSIP: 25245P106
CIK: 1036968
Web: www.diadexus.com
Phone: (650) 246-6400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 4,100,000
Free Float: N/A
Market Cap: $53,000.00
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Kenneth Charles Fang
Chief Medical Officer
Amy Figueroa
Head-Investor Relations

Key Competitors

View All Competitors

DDXS Stock Analysis - Frequently Asked Questions

How were Diadexus' earnings last quarter?: Diadexus, Inc. (OTCMKTS:DDXS) announced its quarterly earnings results on Monday, October, 26th. The company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.69) by $0.35.
What other stocks do shareholders of Diadexus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Diadexus investors own include GoPro (GPRO), General Electric (GE), Ambarella (AMBA) and Alliqua Biomedical (ALQA).
How do I buy shares of Diadexus?: Shares of DDXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DDXS) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial